Considering CD4 count < 200 as a cutoff point for immunodeficiency, there was no statistically-significant difference in the rates of overall complications,19.2% vs. 11.6%, p=0.338, superficial SSI, 0.0% vs. 5.3%, p=1.000, number of procedures, 46.2% vs. 56.8%, p=0.305, mortality, 19.2% vs. 8.5%, p=0.149, and median [IQR] hospital stay, 8 [2-11] vs. 7 [4-14], p=0.181 among HIV+ patients with CD4 counts < 200 and > 200 respectively. The gene discussed is CD4; the disease is immune system disorder.